Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022762129> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2022762129 endingPage "106" @default.
- W2022762129 startingPage "79" @default.
- W2022762129 abstract "The recent marketing of two selective cyclooxygenase-2 (COX-2) inhibitors, celecoxib and rofecoxib is remarkable considering that COX-2 was only discovered eight years ago as a growth factor- and cytokine-inducible gene. Concomitant with these pharmaceutical successes is the advances in our understanding of the molecular and structural basis for selective COX-2 inhibition. This review provides a perspective on the ongoing structure-activity relationship (SAR) efforts in the search of COX-2-specific inhibitors with particular reference to their structural basis for isozyme-specific inhibition. In addition to the existing inhibitor classes, this review will also highlight many novel structural classes which have recently emerged due to a better understanding of the active site differences between the two isozymes with a special emphasis on the modification of the well-established non-steroidal anti-inflammatory drug (NSAID) scaffold. In addition to its role in inflammation, recent studies suggest that COX-2-derived prostaglandins may play a pivotal part in the maintenance of tumor viability, growth, and metastasis. In this review, we summarize the NSAID epidemiological evidence, studies demonstrating overexpression of COX-2 in multiple human tumors and pharmacological evidence in animal models, which indicate that COX-2 inhibitors could be used in the prevention or treatment of a broader range of disease." @default.
- W2022762129 created "2016-06-24" @default.
- W2022762129 creator A5029026901 @default.
- W2022762129 creator A5090896472 @default.
- W2022762129 date "2001-03-01" @default.
- W2022762129 modified "2023-09-27" @default.
- W2022762129 title "Discovery and Design of Selective Cyclooxygenase-2 Inhibitors as Non-Ulcerogenic, Anti-Inflammatory Drugs with Potential Utility as Anti-Cancer Agents" @default.
- W2022762129 doi "https://doi.org/10.2174/1389450013348830" @default.
- W2022762129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11465540" @default.
- W2022762129 hasPublicationYear "2001" @default.
- W2022762129 type Work @default.
- W2022762129 sameAs 2022762129 @default.
- W2022762129 citedByCount "66" @default.
- W2022762129 countsByYear W20227621292012 @default.
- W2022762129 countsByYear W20227621292014 @default.
- W2022762129 countsByYear W20227621292015 @default.
- W2022762129 countsByYear W20227621292016 @default.
- W2022762129 countsByYear W20227621292017 @default.
- W2022762129 countsByYear W20227621292019 @default.
- W2022762129 countsByYear W20227621292020 @default.
- W2022762129 countsByYear W20227621292021 @default.
- W2022762129 crossrefType "journal-article" @default.
- W2022762129 hasAuthorship W2022762129A5029026901 @default.
- W2022762129 hasAuthorship W2022762129A5090896472 @default.
- W2022762129 hasConcept C119795356 @default.
- W2022762129 hasConcept C121608353 @default.
- W2022762129 hasConcept C126322002 @default.
- W2022762129 hasConcept C181199279 @default.
- W2022762129 hasConcept C203014093 @default.
- W2022762129 hasConcept C2776467144 @default.
- W2022762129 hasConcept C2776914184 @default.
- W2022762129 hasConcept C2778582115 @default.
- W2022762129 hasConcept C2779134260 @default.
- W2022762129 hasConcept C2779689624 @default.
- W2022762129 hasConcept C55493867 @default.
- W2022762129 hasConcept C60644358 @default.
- W2022762129 hasConcept C71924100 @default.
- W2022762129 hasConcept C74187038 @default.
- W2022762129 hasConcept C86803240 @default.
- W2022762129 hasConcept C98274493 @default.
- W2022762129 hasConceptScore W2022762129C119795356 @default.
- W2022762129 hasConceptScore W2022762129C121608353 @default.
- W2022762129 hasConceptScore W2022762129C126322002 @default.
- W2022762129 hasConceptScore W2022762129C181199279 @default.
- W2022762129 hasConceptScore W2022762129C203014093 @default.
- W2022762129 hasConceptScore W2022762129C2776467144 @default.
- W2022762129 hasConceptScore W2022762129C2776914184 @default.
- W2022762129 hasConceptScore W2022762129C2778582115 @default.
- W2022762129 hasConceptScore W2022762129C2779134260 @default.
- W2022762129 hasConceptScore W2022762129C2779689624 @default.
- W2022762129 hasConceptScore W2022762129C55493867 @default.
- W2022762129 hasConceptScore W2022762129C60644358 @default.
- W2022762129 hasConceptScore W2022762129C71924100 @default.
- W2022762129 hasConceptScore W2022762129C74187038 @default.
- W2022762129 hasConceptScore W2022762129C86803240 @default.
- W2022762129 hasConceptScore W2022762129C98274493 @default.
- W2022762129 hasIssue "1" @default.
- W2022762129 hasLocation W20227621291 @default.
- W2022762129 hasLocation W20227621292 @default.
- W2022762129 hasOpenAccess W2022762129 @default.
- W2022762129 hasPrimaryLocation W20227621291 @default.
- W2022762129 hasRelatedWork W1968439879 @default.
- W2022762129 hasRelatedWork W1990756964 @default.
- W2022762129 hasRelatedWork W2018808052 @default.
- W2022762129 hasRelatedWork W2053833211 @default.
- W2022762129 hasRelatedWork W2361206304 @default.
- W2022762129 hasRelatedWork W2393019286 @default.
- W2022762129 hasRelatedWork W2532688163 @default.
- W2022762129 hasRelatedWork W4247832209 @default.
- W2022762129 hasRelatedWork W4291014994 @default.
- W2022762129 hasRelatedWork W82350142 @default.
- W2022762129 hasVolume "2" @default.
- W2022762129 isParatext "false" @default.
- W2022762129 isRetracted "false" @default.
- W2022762129 magId "2022762129" @default.
- W2022762129 workType "article" @default.